UnitedHealth Group Incorporated $UNH Shares Acquired by Lincluden Management Ltd.

Lincluden Management Ltd. lifted its position in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 73.1% in the 2nd quarter, according to its most recent filing with the Securities & Exchange Commission. The fund owned 14,408 shares of the healthcare conglomerate’s stock after buying an additional 6,084 shares during the quarter. Lincluden Management Ltd.’s holdings in UnitedHealth Group were worth $4,495,000 at the end of the most recent quarter.

Other hedge funds and other institutional investors have also made changes to their positions in the company. Citizens National Bank Trust Department boosted its stake in shares of UnitedHealth Group by 1.0% during the first quarter. Citizens National Bank Trust Department now owns 17,886 shares of the healthcare conglomerate’s stock valued at $9,368,000 after acquiring an additional 170 shares during the last quarter. Caitlin John LLC boosted its stake in shares of UnitedHealth Group by 14.8% during the first quarter. Caitlin John LLC now owns 862 shares of the healthcare conglomerate’s stock valued at $451,000 after acquiring an additional 111 shares during the last quarter. Triumph Capital Management acquired a new stake in shares of UnitedHealth Group during the second quarter valued at $1,324,000. Wealth Effects LLC boosted its stake in shares of UnitedHealth Group by 14.4% during the second quarter. Wealth Effects LLC now owns 4,688 shares of the healthcare conglomerate’s stock valued at $1,463,000 after acquiring an additional 591 shares during the last quarter. Finally, Arlington Partners LLC acquired a new stake in shares of UnitedHealth Group during the second quarter valued at $2,229,000. Institutional investors and hedge funds own 87.86% of the company’s stock.

Analysts Set New Price Targets

UNH has been the topic of a number of research analyst reports. Morgan Stanley raised their price target on UnitedHealth Group from $325.00 to $395.00 and gave the stock an “overweight” rating in a research note on Friday, September 12th. Mizuho raised their price target on UnitedHealth Group from $300.00 to $430.00 and gave the stock an “outperform” rating in a research note on Thursday. JPMorgan Chase & Co. raised their price target on UnitedHealth Group from $310.00 to $425.00 and gave the stock an “overweight” rating in a research note on Thursday. Barclays raised their price target on UnitedHealth Group from $352.00 to $386.00 and gave the stock an “overweight” rating in a research note on Thursday. Finally, Piper Sandler cut their price objective on UnitedHealth Group from $353.00 to $317.00 and set an “overweight” rating on the stock in a report on Wednesday, July 30th. Sixteen equities research analysts have rated the stock with a Buy rating, seven have issued a Hold rating and four have assigned a Sell rating to the company’s stock. According to data from MarketBeat.com, the company currently has a consensus rating of “Hold” and a consensus target price of $383.09.

UnitedHealth Group Stock Performance

UnitedHealth Group stock opened at $354.30 on Friday. The company has a market cap of $320.88 billion, a price-to-earnings ratio of 15.35, a price-to-earnings-growth ratio of 2.29 and a beta of 0.47. The company has a debt-to-equity ratio of 0.73, a current ratio of 0.85 and a quick ratio of 0.85. UnitedHealth Group Incorporated has a 12 month low of $234.60 and a 12 month high of $630.73. The stock’s 50-day moving average is $318.21 and its 200-day moving average is $349.25.

UnitedHealth Group (NYSE:UNH) last announced its earnings results on Tuesday, July 29th. The healthcare conglomerate reported $4.08 EPS for the quarter, missing the consensus estimate of $4.45 by ($0.37). The company had revenue of $111.62 billion for the quarter, compared to analysts’ expectations of $111.75 billion. UnitedHealth Group had a net margin of 5.04% and a return on equity of 23.32%. The business’s quarterly revenue was up 12.9% compared to the same quarter last year. During the same quarter in the previous year, the business posted $6.80 earnings per share. UnitedHealth Group has set its FY 2025 guidance at 16.000- EPS. Equities analysts anticipate that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current year.

UnitedHealth Group Dividend Announcement

The business also recently announced a quarterly dividend, which was paid on Tuesday, September 23rd. Investors of record on Monday, September 15th were issued a dividend of $2.21 per share. This represents a $8.84 annualized dividend and a dividend yield of 2.5%. The ex-dividend date was Monday, September 15th. UnitedHealth Group’s dividend payout ratio (DPR) is presently 38.30%.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.